Hester Biosciences Limited has submitted a regulatory intimation to BSE Limited and the National Stock Exchange of India Limited.
The purpose of the disclosure is to inform the exchanges of a scheduled meeting of the Company's Board of Directors. The meeting is set to be held on Thursday, 30 July 2026.
The primary agenda for the board meeting is to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended 30 June 2026.
This intimation is made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended from time to time).
The letter was signed and submitted by Vinod Mali, Company Secretary & Compliance Officer, on 23 July 2026 at 16:01:54 IST.